Psychiatric symptoms of long COVID among adults: observational case-control study in Johannesburg, South Africa.
Open Access
- 14 July 2026
- journal article
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (4) , e184
Abstract
Growing research has underscored the elevated prevalence and burden of psychiatric morbidity among adults living with long COVID. The severity of acute SARS-CoV-2 infection may predict the prevalence and severity of psychiatric symptoms in long COVID. Although Global South countries have faced among the highest incidence rates and burden of COVID-19, little is known about the psychiatric symptoms of long COVID in these regions, especially in Sub-Saharan Africa. This study aimed to (a) compare the prevalence of long-term psychiatric symptoms between acute COVID-19 infection groups, (b) estimate the associations between COVID-19 severity and long-term psychiatric symptoms, (c) determine the association between long COVID symptoms and psychiatric symptoms, and (d) test the potential mediating effect of long COVID symptoms in the association between acute COVID-19 infection and psychiatric symptoms. This case-control study took place in Johannesburg, South Africa, between August 2022 and July 2023. A total of 360 adults were categorised into one of four case groups based on initial COVID-19 symptoms: asymptomatic, symptomatic, admitted to hospital and vaccinated controls. Prevalence rates of post-traumatic stress disorder (21.1%) and somatic symptoms (22.9%) were elevated. Individuals with symptomatic COVID-19 exhibited the greatest psychiatric morbidity out of all groups, exhibiting the highest levels of depression, suicidality, anxiety, post-traumatic stress disorder, bipolar disorder and somatisation. Acute COVID-19 severity was associated with worse symptoms of depression, somatisation and physical fatigue. Severity of long COVID symptoms was directly associated with psychiatric sequelae. These results call attention to the long-term psychiatric sequelae of SARS-CoV-2 infection and early identification and management of emerging psychiatric symptoms in high-risk COVID-19 survivors.Keywords
This publication has 40 references indexed in Scilit:
- Evaluating the Buffering Role of Perceived Social Support and Coping Resources Against the Adult Mental Health Impacts of COVID-19 Psychosocial Stress: A Cross-Sectional Study in South AfricaAdversity and Resilience Science, 2024
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and MaliInternational Journal of Infectious Diseases, 2024
- Factors associated with mental health outcomes after COVID-19: A 24-month follow-up longitudinal studyGeneral Hospital Psychiatry, 2023
- Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndromeEBioMedicine, 2023
- Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causesBrain, Behavior, and Immunity, 2023
- The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysiseClinicalMedicine, 2022
- Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their ResolutionJAMA Network Open, 2022
- A clinical case definition of post-COVID-19 condition by a Delphi consensusThe Lancet Infectious Diseases, 2021
- Characterizing long COVID in an international cohort: 7 months of symptoms and their impacteClinicalMedicine, 2021